Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
$310,000Y01FY2019AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To support the development and assessment of two live microbiome-based products.
View original record on NIH RePORTER →